.svg)
BLOG
The Latest on Solid IO
Solid IO welcomes new international investors
Leo Capital and Life Science Invest have joined Solid IO to support the company's next phase of growth in personalized immuno-oncology.
Organ-on-Chip: A Breakthrough in Biomedical Research
For decades, scientists have relied on cell cultures and animal models to study diseases and test new drugs. Now, organ-on-chip (OoC) technology is set to change that.
Solid IO Launches on World Cancer Day: A New Era in Precision Oncology
On World Cancer Day, Solid IO officially launches, marking the beginning of a mission to end guesswork in cancer care.
Breaking New Ground in Personalized Cancer Care
Solid IO’s first publication showcases advances in tumor-on-chip technology
Shape the future of cancer care
Join SolidIO in transforming cancer care with groundbreaking organ-on-chip technology. We’re calling on researchers, clinicians, and investors to partner with us in advancing precision medicine, accelerating innovation, and expanding global access to personalized oncology. Together, we can bring clarity and better outcomes to cancer care worldwide.